Related Experiment Video
Updated: Aug 11, 2025

Rescue of Recombinant Newcastle Disease Virus from cDNA
Published on: October 11, 2013
Chicken-derived MERTK protein inhibits Newcastle disease virus replication by increasing STAT1 phosphorylation in
Lei Tan1, Meizhen Huang2, Xusheng Qiu2
1Department of Avian Diseases, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai 200241, China; Shanghai Key Laboratory of Veterinary Biotechnology, Shanghai, People's Republic of China.
Abstract:
The receptor tyrosine kinases TYRO3, AXL, and MERTK (TAM) are transmembrane proteins associated with the regulation of the innate immune response. In this study, the role of the chicken-derived MERTK protein (chMertk) in the regulation of the type I interferon (IFN) signaling pathway and its antiviral effect were investigated in vitro. Newcastle disease (ND) caused by the Newcastle disease virus (NDV) is able to widely spread in chickens and give rise to massive losses in the poultry industry around the world. We found that the overexpression of the exogenous chMertk upregulated the STAT1 phosphorylation and the expression of IFN-stimulated gene IFITM3 and significantly reduced the NDV titer (p < 0.05). A mutation assay showed that three tyrosine residues (Y739, Y743, and Y744) in chMertk promoted STAT1 phosphorylation and inhibited NDV replication. However, the chicken-derived E3 ubiquitin ligase CBL significantly negatively regulated chMertk expression, thus attenuating STAT1 phosphorylation. chMertk function was restored by the ubiquitin-proteasome inhibitor MG132, demonstrating that chMertk was controlled by Casitas B-lineage proto-oncogene (CBL) ubiquitination and degradation. Together, these results suggested that chMertk participated in regulating the immune responses to NDV infection, and that CBL significantly downregulated the expression of chMertk through its ubiquitination and degradation, to maintain cellular homeostasis. Overall, our study provided new insights into the role of chMertk in regulating the innate immune response and its anti-NDV activity.
Insights
Chicken Mertk protein enhances the type I interferon response against Newcastle disease virus (NDV). Casitas B-lineage proto-oncogene (CBL) negatively regulates Mertk, impacting STAT1 phosphorylation and antiviral activity.
Area of Science:
- Immunology
- Virology
- Molecular Biology
Background:
- Receptor tyrosine kinases TYRO3, AXL, and MERTK (TAM) are key regulators of innate immunity.
- Newcastle disease virus (NDV) causes significant economic losses in the poultry industry worldwide.
- Understanding the innate immune response to NDV is crucial for developing effective control strategies.
Purpose of the Study:
- To investigate the role of chicken MERTK (chMertk) in regulating the type I interferon (IFN) signaling pathway.
- To determine the antiviral effect of chMertk against NDV in vitro.
- To elucidate the regulatory mechanism of chMertk by other cellular factors.
Main Methods:
- Overexpression of exogenous chMertk in chicken cells.
- Mutation assay to identify key tyrosine residues in chMertk.
- Analysis of STAT1 phosphorylation and IFN-stimulated gene expression (IFITM3).
- Measurement of NDV titer.
- Investigation of chMertk regulation by chicken E3 ubiquitin ligase CBL and the effect of the proteasome inhibitor MG132.
Main Results:
- Overexpression of chMertk upregulated STAT1 phosphorylation and IFITM3 expression, significantly reducing NDV titer.
- Specific tyrosine residues (Y739, Y743, Y744) in chMertk were found to promote STAT1 phosphorylation and inhibit NDV replication.
- Chicken CBL negatively regulated chMertk expression, attenuating STAT1 phosphorylation.
- chMertk function was restored by MG132, indicating CBL-mediated ubiquitination and degradation of chMertk.
Conclusions:
- chMertk plays a significant role in the innate immune response against NDV infection.
- CBL negatively regulates chMertk expression via ubiquitination and degradation, contributing to cellular homeostasis.
- These findings offer new insights into chMertk's function in innate immunity and its anti-NDV activity.

